Bora Biologics and Protect Animal Health Form Long-Term Collaboration on Antibody Products

Bora Biologics, a contract development and manufacturing organization (CDMO) based in the U.S., has partnered with Protect Animal Health, a biotechnology firm focused on antibody-based veterinary solutions, to collaborate on multiple projects targeting the animal health market. This long-term agreement will involve the development and manufacturing of at least three antibody-based programs, which include two monoclonal antibody programs and one bispecific antibody program.

This partnership represents Bora Biologics' first venture into the animal health sector and aims to broaden the company’s biologics development and manufacturing capabilities. The collaboration will assist Protect Animal Health throughout the development process, including cell line development, process development, scale-up, and manufacturing, leveraging Bora Biologics' networks in the U.S. and Taiwan.

Haolin Sung, President of Protect Animal Health, expressed enthusiasm about the partnership, highlighting Bora’s technical expertise and infrastructure as pivotal to advancing their animal health product pipeline. Bora Biologics utilizes a CHO-K1 cell line platform, which is effective for developing complex recombinant proteins like monoclonal antibodies.

Jennifer Kuan, CEO of Bora Biologics, emphasized that this collaboration not only extends their offerings into the animal health domain but also showcases their capabilities in manufacturing and developing advanced biologics products. Protect Animal Health aims to create a diverse range of veterinary therapeutics to address unmet needs in the market, and the support from Bora Biologics is expected to facilitate this mission.

Steven Huang, Global Business Development Director at Bora Biologics, remarked on the significant opportunities in biologics innovation for animal health and indicated that the partnership would reinforce their capacity to provide development and manufacturing expertise in this area.

Both companies are strategically positioned to contribute to advancements in veterinary medicine, with Protect Animal Health focusing on innovative biologics and Bora Biologics offering comprehensive manufacturing services aimed at global markets. Protect Animal Health, headquartered in Taiwan, is working to establish a global network of development and partnerships spanning the U.S., Europe, and Asia.